Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.

Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection. Vaccine. 2021 07 05; 39(30):4063-4071.

View in: PubMed

subject areas

Animals
Antibodies, Neutralizing
Antibodies, Viral
Child
Humans
Infant
Papio
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus Vaccines
Respiratory Syncytial Virus, Human
Vaccination
Virus Replication

authors with profiles

James Frederick Papin
Vadim A Ivanov
Zhongxin Yu